On March 12, 2026, Colossal Biosciences opened its Dallas, Texas headquarters to media for the first time, revealing what it describes as the world’s most advanced genome engineering lab and the operational center of a $615 million de-extinction effort. The company says it has raised $615 million across its operations; the headquarters occupies the second floor of an office building just west of downtown Dallas, and Colossal reports the lab consolidates gene-editing, conservation, and reproductive technology work under one roof.
The technical significance is not the revival claims themselves, but the maturation of end-to-end biological infrastructure: genome engineering, reproductive biology, ancient-genome reconstruction, and biobanking. Colossal says its platform is being applied beyond extinct-species projects to conservation uses such as an mRNA vaccine for elephant EEHV, genetic rescue of red wolves, AI-powered bioacoustic monitoring, and disease- and toxin-resistance engineering for amphibians and the northern quoll; it has also announced a Dubai BioVault targeting preservation of samples from more than 10,000 species.
For the Ark, the actionable takeaway is to track this class of infrastructure as dual-use survival technology: high-throughput DNA storage, cryopreservation, reproductive control, and trait engineering could become critical for off-world biospheres and Earth-restoration after catastrophe. The team should monitor whether Colossal or similar programs produce scalable protocols for cell-line preservation, genomic reference libraries, synthetic embryos, and species-rescue workflows that could be adapted into lunar biobanking and restoration systems.